Clinical trials for Fibrodysplasia ossificans progressiva
6 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT06724562IL1 Inhibition in FOPUniversity of California, San Francisco · PI: Edward Hsiao, MD, PhD
- RECRUITINGNCT06089616A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)Ipsen · PI: Ipsen Medical, Director
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT06508021A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)Ashibio Inc
- ACTIVE NOT RECRUITINGPhase 3NCT05394116A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)Regeneron Pharmaceuticals · PI: Clinical Trial Management
- RECRUITINGPhase 2NCT05090891To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans ProgressivaIncyte Corporation · PI: Amanda McBride, MD
- RECRUITINGNCT02745158The Fibrodysplasia Ossificans Progressiva (FOP) Connection RegistryThe International FOP Association · PI: Betsy Bogard, BS, MS